Strizki, J. M., Xu, S., Wagner, N. E., Wojcik, L., Liu, J., Hou, Y., . . . Baroudy, B. M. (2001). SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. The National Academy of Sciences.
Chicago Style CitationStrizki, Julie M., et al. SCH-C (SCH 351125), an Orally Bioavailable, Small Molecule Antagonist of the Chemokine Receptor CCR5, Is a Potent Inhibitor of HIV-1 Infection in Vitro and in Vivo. The National Academy of Sciences, 2001.
Cita MLAStrizki, Julie M., et al. SCH-C (SCH 351125), an Orally Bioavailable, Small Molecule Antagonist of the Chemokine Receptor CCR5, Is a Potent Inhibitor of HIV-1 Infection in Vitro and in Vivo. The National Academy of Sciences, 2001.